Drug information for SOLIFENACIN SUCCINATE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET; ORAL 10MG Tentative Approval   SOLIFENACIN SUCCINATE solifenacin succinate TEVA PHARMS USA 91464
TABLET; ORAL 5MG Tentative Approval   SOLIFENACIN SUCCINATE solifenacin succinate TEVA PHARMS USA   "

Drug Adverse Effects information for SOLIFENACIN SUCCINATE

Role code Indications Reaction # Reports
PS HYPERTONIC BLADDER CHEST DISCOMFORT 1
PS HYPERTONIC BLADDER DIZZINESS 1
PS HYPERTONIC BLADDER DYSPNOEA 1
PS URINARY INCONTINENCE TRANSITIONAL CELL CARCINOMA 1
SS HERPES ZOSTER OPHTHALMIC NEUROTOXICITY 1
C ABSCESS ANAPHYLACTIC REACTION 1
C ACUTE PSYCHOSIS ALCOHOL ABUSE 1
C ACUTE PSYCHOSIS BLOOD ALCOHOL INCREASED 1
C ACUTE PSYCHOSIS DRUG INEFFECTIVE 2
C ACUTE PSYCHOSIS SCHIZOPHRENIA, PARANOID TYPE 2
C ACUTE PSYCHOSIS SINUS TACHYCARDIA 2
C ACUTE PSYCHOSIS URINARY TRACT INFECTION 2
C ACUTE PSYCHOSIS WHITE BLOOD CELL COUNT INCREASED 2
C AGE-RELATED MACULAR DEGENERATION TRANSIENT ISCHAEMIC ATTACK 1
C BACK PAIN ALCOHOL ABUSE 1
C BACK PAIN BLOOD ALCOHOL INCREASED 1
C BACK PAIN DRUG INEFFECTIVE 2
C BACK PAIN SCHIZOPHRENIA, PARANOID TYPE 2
C BACK PAIN SINUS TACHYCARDIA 2
C BACK PAIN URINARY TRACT INFECTION 2
C BACK PAIN WHITE BLOOD CELL COUNT INCREASED 2
C BLOOD CALCIUM DECREASED MALAISE 2
C BLOOD CALCIUM DECREASED NEUTROPENIA 2
C BLOOD CALCIUM DECREASED NEUTROPHIL COUNT DECREASED 2
C BLOOD CALCIUM DECREASED NEUTROPHIL COUNT INCREASED 2
C BLOOD CALCIUM DECREASED ORAL HERPES 2
C BLOOD CALCIUM DECREASED PYREXIA 2
C BLOOD CALCIUM DECREASED WHITE BLOOD CELL COUNT DECREASED 2
C BLOOD CHOLESTEROL INCREASED HYPERHIDROSIS 1
C BLOOD CHOLESTEROL INCREASED MYALGIA 1
C CATAPLEXY ATRIAL FIBRILLATION 1
C CATAPLEXY PALPITATIONS 1
C CONSTIPATION MALAISE 2
C CONSTIPATION NEUTROPENIA 2
C CONSTIPATION NEUTROPHIL COUNT DECREASED 2
C CONSTIPATION NEUTROPHIL COUNT INCREASED 2
C CONSTIPATION ORAL HERPES 2
C CONSTIPATION PYREXIA 2
C CONSTIPATION WHITE BLOOD CELL COUNT DECREASED 2
C CYSTITIS INTERSTITIAL ALOPECIA 1
C CYSTITIS INTERSTITIAL OFF LABEL USE 1
C CYSTITIS INTERSTITIAL SKIN BURNING SENSATION 1
C CYSTITIS INTERSTITIAL VISION BLURRED 1
C DEPRESSION MALAISE 2
C DEPRESSION NEUTROPENIA 2
C DEPRESSION NEUTROPHIL COUNT DECREASED 2
C DEPRESSION NEUTROPHIL COUNT INCREASED 2
C DEPRESSION ORAL HERPES 2
C DEPRESSION PYREXIA 2
C DEPRESSION WHITE BLOOD CELL COUNT DECREASED 2
C DIABETES MELLITUS MALAISE 2
C DIABETES MELLITUS NEUTROPENIA 2
C DIABETES MELLITUS NEUTROPHIL COUNT DECREASED 2
C DIABETES MELLITUS NEUTROPHIL COUNT INCREASED 2
C DIABETES MELLITUS ORAL HERPES 2
C DIABETES MELLITUS PYREXIA 2
C DIABETES MELLITUS WHITE BLOOD CELL COUNT DECREASED 2
C GENERAL PHYSICAL CONDITION ALCOHOL ABUSE 5
C GENERAL PHYSICAL CONDITION BLOOD ALCOHOL INCREASED 5
C GENERAL PHYSICAL CONDITION DRUG INEFFECTIVE 10
C GENERAL PHYSICAL CONDITION SCHIZOPHRENIA, PARANOID TYPE 10
C GENERAL PHYSICAL CONDITION SINUS TACHYCARDIA 10
C GENERAL PHYSICAL CONDITION URINARY TRACT INFECTION 10
C GENERAL PHYSICAL CONDITION WHITE BLOOD CELL COUNT INCREASED 10
C HEPATO-LENTICULAR DEGENERATION GASTROINTESTINAL HAEMORRHAGE 1
C HERPES ZOSTER OPHTHALMIC AGITATION 4
C HERPES ZOSTER OPHTHALMIC ANAPHYLACTIC REACTION 1
C HERPES ZOSTER OPHTHALMIC BLISTER 2
C HERPES ZOSTER OPHTHALMIC BLOOD CREATININE INCREASED 3
C HERPES ZOSTER OPHTHALMIC BLOOD POTASSIUM INCREASED 2
C HERPES ZOSTER OPHTHALMIC BLOOD PRESSURE INCREASED 2
C HERPES ZOSTER OPHTHALMIC BLOOD PRESSURE SYSTOLIC INCREASED 2
C HERPES ZOSTER OPHTHALMIC BLOOD SODIUM DECREASED 4
C HERPES ZOSTER OPHTHALMIC BLOOD UREA INCREASED 3
C HERPES ZOSTER OPHTHALMIC CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1
C HERPES ZOSTER OPHTHALMIC CONFUSIONAL STATE 4
C HERPES ZOSTER OPHTHALMIC CREATININE RENAL CLEARANCE DECREASED 2
C HERPES ZOSTER OPHTHALMIC DISORIENTATION 3
C HERPES ZOSTER OPHTHALMIC DRUG INTOLERANCE 1
C HERPES ZOSTER OPHTHALMIC EXFOLIATIVE RASH 1
C HERPES ZOSTER OPHTHALMIC EYE DISCHARGE 1
C HERPES ZOSTER OPHTHALMIC EYE SWELLING 2
C HERPES ZOSTER OPHTHALMIC HALLUCINATION, VISUAL 4
C HERPES ZOSTER OPHTHALMIC INCORRECT DOSE ADMINISTERED 1
C HERPES ZOSTER OPHTHALMIC MENTAL STATUS CHANGES 4
C HERPES ZOSTER OPHTHALMIC NEUROTOXICITY 3
C HERPES ZOSTER OPHTHALMIC PERIORBITAL OEDEMA 2
C HERPES ZOSTER OPHTHALMIC RASH ERYTHEMATOUS 2
C HERPES ZOSTER OPHTHALMIC RESPIRATORY RATE INCREASED 1
C HERPES ZOSTER OPHTHALMIC RHONCHI 3
C HERPES ZOSTER OPHTHALMIC SKIN EXFOLIATION 1
C HERPES ZOSTER OPHTHALMIC VISION BLURRED 3
C HYPERSENSITIVITY MALAISE 2
C HYPERSENSITIVITY NEUTROPENIA 2
C HYPERSENSITIVITY NEUTROPHIL COUNT DECREASED 2
C HYPERSENSITIVITY NEUTROPHIL COUNT INCREASED 2
C HYPERSENSITIVITY ORAL HERPES 2
C HYPERSENSITIVITY PYREXIA 2
C HYPERSENSITIVITY WHITE BLOOD CELL COUNT DECREASED 2
C HYPERTHYROIDISM MALAISE 2
C HYPERTHYROIDISM NEUTROPENIA 2
C HYPERTHYROIDISM NEUTROPHIL COUNT DECREASED 2
C HYPERTHYROIDISM NEUTROPHIL COUNT INCREASED 2
C HYPERTHYROIDISM ORAL HERPES 2
C HYPERTHYROIDISM PYREXIA 2
C HYPERTHYROIDISM WHITE BLOOD CELL COUNT DECREASED 2
C HYPERTONIC BLADDER ALOPECIA 2
C HYPERTONIC BLADDER OFF LABEL USE 1
C HYPERTONIC BLADDER SKIN BURNING SENSATION 2
C HYPERTONIC BLADDER VISION BLURRED 2
C MULTIPLE SCLEROSIS ERYTHEMA 2
C MULTIPLE SCLEROSIS HYPERSENSITIVITY 2
C MULTIPLE SCLEROSIS RASH 2
C MULTIPLE SCLEROSIS SWELLING 2
C PRODUCT USED FOR UNKNOWN INDICATION ANAPHYLACTIC REACTION 6
C PRODUCT USED FOR UNKNOWN INDICATION BRONCHITIS 11
C PRODUCT USED FOR UNKNOWN INDICATION CHRONIC OBSTRUCTIVE PULMONARY DISEASE 11
C PRODUCT USED FOR UNKNOWN INDICATION CUTANEOUS VASCULITIS 18
C PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 3
C PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE HAEMATOMA 5
C PRODUCT USED FOR UNKNOWN INDICATION VASCULITIC RASH 27
C RESPIRATORY TRACT INFECTION ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2
C RESPIRATORY TRACT INFECTION ASPIRATION 2
C RESPIRATORY TRACT INFECTION COMPLETED SUICIDE 2
C RESPIRATORY TRACT INFECTION MALAISE 2
C RESPIRATORY TRACT INFECTION OVERDOSE 2
C RESPIRATORY TRACT INFECTION RESPIRATORY TRACT INFECTION 2
C RESPIRATORY TRACT INFECTION TOXICITY TO VARIOUS AGENTS 2
C RHEUMATOID ARTHRITIS BRONCHITIS 3
C RHEUMATOID ARTHRITIS CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
C SCHIZOPHRENIA ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 4
C SCHIZOPHRENIA ASPIRATION 4
C SCHIZOPHRENIA COMPLETED SUICIDE 2
C SCHIZOPHRENIA MALAISE 6
C SCHIZOPHRENIA NEUTROPENIA 2
C SCHIZOPHRENIA NEUTROPHIL COUNT DECREASED 2
C SCHIZOPHRENIA NEUTROPHIL COUNT INCREASED 2
C SCHIZOPHRENIA ORAL HERPES 2
C SCHIZOPHRENIA OVERDOSE 3
C SCHIZOPHRENIA PYREXIA 2
C SCHIZOPHRENIA RESPIRATORY TRACT INFECTION 4
C SCHIZOPHRENIA TOXICITY TO VARIOUS AGENTS 2
C SCHIZOPHRENIA WHITE BLOOD CELL COUNT DECREASED 2
C SKIN INFECTION MALAISE 8
C SKIN INFECTION NEUTROPENIA 8
C SKIN INFECTION NEUTROPHIL COUNT DECREASED 8
C SKIN INFECTION NEUTROPHIL COUNT INCREASED 8
C SKIN INFECTION ORAL HERPES 8
C SKIN INFECTION PYREXIA 8
C SKIN INFECTION WHITE BLOOD CELL COUNT DECREASED 8
C SMOKING CESSATION THERAPY HYPERSENSITIVITY 1
Ads by Google